Approval · Notice of Compliance 8727 · 2007
CLIMARA PRO: Notice of Compliance 8727
Issued April 18, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8727
- Date
- April 18, 2007
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Estrogen & progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLIMARA PRO | 02250616 | Cancelled Post Market |
Medicinal ingredients
- ESTRADIOL 4.4 MG per PAD
- LEVONORGESTREL 1.39 MG per PAD